From catching cancer to creating life, artificial intelligence (AI) is rewriting the rules of medicine, and how!<\/p>\n
It is now being used by scientists in Taiwan to diagnose schizophrenia.<\/p>\n
As per a report on Taipei Times, researchers at Taipei Veterans General Hospital (TVGH) have developed an artificial intelligence-powered platform capable of helping diagnose schizophrenia.<\/p>\n
AI peeks into minds<\/p>\n
The tools, a first-of-its-kind in the world, mark a major leap forward in the world of psychiatric care, long hampered by subjectivity and guesswork.<\/p>\n
Named BrainProbe, the tool analyzes magnetic resonance imaging (MRI) scans to detect structural and functional changes in the brain associated with schizophrenia.<\/p>\n
With an accuracy rate of 91.7 percent, it\u2019s the world\u2019s first AI tool of its kind and a dramatic departure from traditional methods that rely heavily on clinical interviews and behavioral observation.<\/p>\n
\u201cThe field of psychiatry has long hoped to identify objective biological markers that can help quantify the symptoms [of mental illness],\u201d TVGH Medical AI Development Center deputy director Albert Yang was quoted as saying by Taipei Times.<\/p>\n
Schizophrenia is a complex mental disorder characterized by hallucinations, delusions, and cognitive disruptions. <\/p>\n
Despite decades of research, diagnoses are still mostly based on self-reported symptoms and physician interpretation, leaving room for misdiagnosis and delayed treatment. <\/p>\n
This subjective approach often overlooks subtle biological markers, making early detection difficult and preventing timely, personalized interventions that could significantly improve patient outcomes.<\/p>\n
AI picks early signs<\/p>\n
With that challenge in mind, Yang\u2019s team turned to artificial intelligence. Using more than a decade of brain scan data from over 1,500 individuals, including both healthy and those diagnosed with schizophrenia, the AI tool was trained to detect subtle, early-stage changes invisible to the human eye.<\/p>\n
One such case involved a 30-year-old man experiencing auditory hallucinations <\/a>and paranoid delusions. \u201cBrainProbe was able to detect signs of degeneration in his brain function and structure, particularly in deeper regions such as the insula and temporal lobe,\u201d Yang said.<\/p>\n \u201cAbnormalities associated with schizophrenia prompted further evaluation, and the man was later confirmed to have the dis<\/a>e<\/a>ase<\/a>.\u201d<\/p>\n More than just a diagnostic tool, BrainProbe can also track how the brain changes over time.<\/p>\n \u201cThe most important capability of BrainProbe is its ability to track changes in the brain as it ages,\u201d Yang said. \u201cIt has established a brain aging prediction index and a mechanism for monitoring pathological changes.\u201d<\/p>\n The technology is currently being offered at TVGH through a self-pay clinical trial program while awaiting approval from Taiwan\u2019s Food and Drug Administration.<\/p>\n